On ECHEMI
Home > Drugs > GRAND PHARMACEUTICAL(China) Co., Ltd.
GRAND PHARMACEUTICAL(China) Co., Ltd.
  • Founded in:

    1990-02-24
  • Country:

    China China
  • Address:

    No. 1-6, 23F, Building 1, No. 160, Qiaokou Road, Qiaokou District, Wuhan City, Hubei Province
  • Tax NO.:

    91420100707162257C
  • Registered Funds:

    2351.254765 yuan
  • Website:

  • Email:

Related Drugs
Analgin Tablets
The main ingredient of this product is analgin, and its chemical name is [(1,5-dimethyl-2-phenyl-3-oxo-2,3-dihydro-1H-pyrazol-4-yl)methylamino]methanesulfonic acid sodium salt hydrate. Molecular formula: C13H16N3NaO4SH2O Molecular weight: 351.36
Name Description Content CAS NO. Registered Holders
Metamizole Sodium Monohydrate

The antipyretic and analgesic effects are faster and stronger than those of aminopyrine.

More

The antipyretic and analgesic effects are faster and stronger than those of aminopyrine.

5907-38-0 9
Compound acetylsalicylic acid tablets
Acetylsalicylic acid.
Name Description Content CAS NO. Registered Holders
Acetylsalicylic acid

Analgesic, anti-inflammatory, antipyretic, anti-rheumatic, inhibiting platelet aggregation

More

Analgesic, anti-inflammatory, antipyretic, anti-rheumatic, inhibiting platelet aggregation

50-78-2 35
Fluorouracil Tablets
Name Description Content CAS NO. Registered Holders
5-Fluorouracil

Extract from the above information

More

Extract from the above information

51-21-8 21
Trimetazidine Hydrochloride Tablets
The active ingredient of this product is trimetazidine hydrochloride, its chemical name: 1-(2,3,4-trimethoxybenzyl)piperazine dihydrochloride, molecular formula: C14H22N2O3.2HCL molecular weight: 339.3
Name Description Content CAS NO. Registered Holders
Trimetazidine dihydrochloride

By protecting the energy metabolism of cells under hypoxia or ischemia, preventing the decrease of intracellular ATP levels, it ensures the normal function of ion pumps and the normal operation of transmembrane sodium-potassium flow, and maintains the stability of the intracellular environment. Animal studies have shown that it can help maintain the energy metabolism of the heart and nerve sensory organs under ischemia and hypoxia, reduce intracellular acidosis and changes in transmembrane ion flow caused by ischemia, reduce the movement and infiltration of multinuclear neutrophils during ischemia and myocardial reperfusion, reduce the scope of experimental infarction, and have no significant effect on hemodynamics. Human studies have shown that it can increase coronary blood flow reserve, delay the occurrence of exercise-induced ischemia, limit rapid fluctuations in blood pressure without significant changes in heart rate, reduce the frequency of angina attacks, and reduce the use of glyceryl trinitrate.

More

By protecting the energy metabolism of cells under hypoxia or ischemia, preventing the decrease of intracellular ATP levels, it ensures the normal function of ion pumps and the normal operation of transmembrane sodium-potassium flow, and maintains the stability of the intracellular environment. Animal studies have shown that it can help maintain the energy metabolism of the heart and nerve sensory organs under ischemia and hypoxia, reduce intracellular acidosis and changes in transmembrane ion flow caused by ischemia, reduce the movement and infiltration of multinuclear neutrophils during ischemia and myocardial reperfusion, reduce the scope of experimental infarction, and have no significant effect on hemodynamics. Human studies have shown that it can increase coronary blood flow reserve, delay the occurrence of exercise-induced ischemia, limit rapid fluctuations in blood pressure without significant changes in heart rate, reduce the frequency of angina attacks, and reduce the use of glyceryl trinitrate.

13171-25-0 31
Tiapride Hydrochloride Tablets
The main ingredient of this product is tiapride hydrochloride.
Name Description Content CAS NO. Registered Holders
Tiapride hydrochloride

This product belongs to the benzamide antipsychotic drug, which has an inhibitory effect on the hyperfunction of dopaminergic nerves in the midbrain limbic system and an antagonistic effect on dopaminergic nerve movement disorders in the striatum, thereby producing a calming and sedative effect. It is characterized by its good effect on sensory and motor neurological diseases and psychomotor behavioral disorders. Animal experiments have confirmed that this product can block the conduction of pain impulses through the spinal thalamic tract to the reticular formation. The analgesic effect of this drug may be related to the integration of pain impulses by the thalamus. In addition, it has an antiemetic effect.

More

This product belongs to the benzamide antipsychotic drug, which has an inhibitory effect on the hyperfunction of dopaminergic nerves in the midbrain limbic system and an antagonistic effect on dopaminergic nerve movement disorders in the striatum, thereby producing a calming and sedative effect. It is characterized by its good effect on sensory and motor neurological diseases and psychomotor behavioral disorders. Animal experiments have confirmed that this product can block the conduction of pain impulses through the spinal thalamic tract to the reticular formation. The analgesic effect of this drug may be related to the integration of pain impulses by the thalamus. In addition, it has an antiemetic effect.

51012-33-0 12
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.